Ad R. Hermus

Nijmegen, GE, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

TP53 mutations in functional corticotroph tumors are linked to invasion and worse clinical outcome.

TP53 mutations in functional corticotroph tumors are linked to invasion and worse clinical outcome.

Journal: Acta neuropathologica communications

Published: July 04, 2022

Health-Related Quality of Life in Patients with Multiple Endocrine Neoplasia Type 1.

Health-Related Quality of Life in Patients with Multiple Endocrine Neoplasia Type 1.

Journal: Neuroendocrinology

Published: October 08, 2019

Driver mutations in USP8 wild-type Cushing's disease.

Driver mutations in USP8 wild-type Cushing's disease.

Journal: Neuro-oncology

Published: June 22, 2019

DNA methylation profiling in MEN1-related pancreatic neuroendocrine tumors reveals a potential epigenetic target for treatment.

DNA methylation profiling in MEN1-related pancreatic neuroendocrine tumors reveals a potential epigenetic target for treatment.

Journal: European journal of endocrinology

Published: March 07, 2018

High Fear of Disease Occurrence Is Associated With Low Quality of Life in Patients With Multiple Endocrine Neoplasia Type 1: Results From the Dutch MEN1 Study Group.

High Fear of Disease Occurrence Is Associated With Low Quality of Life in Patients With Multiple Endocrine Neoplasia Type 1: Results From the Dutch MEN1 Study Group.

Journal: The Journal of clinical endocrinology and metabolism

Published: January 31, 2018

Somatic USP8 mutations are frequent events in corticotroph tumor progression causing Nelson's tumor.

Somatic USP8 mutations are frequent events in corticotroph tumor progression causing Nelson's tumor.

Journal: European journal of endocrinology

Published: August 02, 2017

Expression of p27Kip1 and p18Ink4c in human multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors.

Expression of p27Kip1 and p18Ink4c in human multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors.

Journal: Journal of endocrinological investigation

Published: April 22, 2017

Management of MEN1 Related Nonfunctioning Pancreatic NETs: A Shifting Paradigm: Results From the DutchMEN1 Study Group.

Management of MEN1 Related Nonfunctioning Pancreatic NETs: A Shifting Paradigm: Results From the DutchMEN1 Study Group.

Journal: Annals of surgery

Published: March 04, 2017

PROGNOSTIC FACTORS FOR SURVIVAL OF MEN1 PATIENTS WITH DUODENOPANCREATIC TUMORS METASTATIC TO THE LIVER: RESULTS FROM THE DMSG.

PROGNOSTIC FACTORS FOR SURVIVAL OF MEN1 PATIENTS WITH DUODENOPANCREATIC TUMORS METASTATIC TO THE LIVER: RESULTS FROM THE DMSG.

Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Published: February 23, 2017

Rare NOX3 Variants Confer Susceptibility to Agranulocytosis During Thyrostatic Treatment of Graves' Disease.

Rare NOX3 Variants Confer Susceptibility to Agranulocytosis During Thyrostatic Treatment of Graves' Disease.

Journal: Clinical pharmacology and therapeutics

Published: February 15, 2017

Prognostic value of WHO grade in pancreatic neuro-endocrine tumors in Multiple Endocrine Neoplasia type 1: Results from the DutchMEN1 Study Group.

Prognostic value of WHO grade in pancreatic neuro-endocrine tumors in Multiple Endocrine Neoplasia type 1: Results from the DutchMEN1 Study Group.

Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

Published: January 06, 2017

Enhanced self-efficacy after a self-management programme in pituitary disease: a randomized controlled trial.

Enhanced self-efficacy after a self-management programme in pituitary disease: a randomized controlled trial.

Journal: European journal of endocrinology

Published: December 12, 2016

Showing 1-12 of 28

Last Updated: 09/26/2026